Table 6 Impact of donor age on prevalence of TTIs
Male | Female | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Donation Number | Age (Year) | Number of confirmed positive samples Prevalence /100000 donation (95% CI) | Donation Number | Age (Year) | Number of confirmed positive samples Prevalence /100000 donation (95% CI) | ||||||
HBV | HIV | HCV | HTLV 1/2 | HBV | HIV | HCV | HTLV 1/2 | ||||
3,436,921 | < 29 | 1236 36 (32.4–39.9) | 24 0.7 (0.4–1.4) | 215 6.3 (4.9–8) | 505 14.7 (12.5–17.2) | 185,939 | < 29 | 78 41.9 (38–46) | 3 1.6 (1–2.6) | 11 5.9 (4.5–7.6) | 61 32.8 (29.4–36.5) |
P value | 0.2 | 0.2 | 0.2 | 0.0001 | |||||||
aChi-square Pearson value | 1.7 | 1.9 | 1.7 | 37.1 | |||||||
30–39 | 1894 55.1 (50.6–59.8) | 41 1.2 (0.7–2.1) | 553 16.1 (13.7–18.7) | 716 20.8 (18.2–23.8) | 30–39 | 113 60.8 (56.1–65.8) | 1 0.5 (0.2–1.2) | 13 7 (5.5–8.8) | 112 60.2 (55.6–65.2) | ||
P value | 0.1 | 0.7 | 0.002 | 0.0001 | |||||||
Chi-square Pearson value | 1.02 | 0.6 | 9.3 | 119.8 | |||||||
40–49 | 1538 44.7 (40.7–49) | 10 0.3 (0.1–0.8) | 292 8.5 (6.8–10.5) | 609 17.7 (15.2–20.5) | 40–49 | 125 67.2 (62.3–72.4) | 2 1.1 (0.6–1.9) | 15 8.1 (6.5–10) | 158 85 (79.4–90.9) | ||
P value | 0.0001 | 0.1 | 0.9 | 0.0001 | |||||||
Chi-square Pearson value | 19.4 | 3.3 | 0.03 | 376.9 | |||||||
> 50 | 938 27.3 (24.2–30.7) | 6 0.2 (0.05–0.7) | 139 4 (2.9–5.4) | 385 11.2 (9.7–14) | > 50 | 88 47.3 (43.2–51.7) | 1 0.5 (0.2–1.2) | 14 7.5 (5.6–9.4) | 116 62.4 (57.7–67.5) | ||
P value | 0.0001 | 0.3 | 0.0001 | 0.0001 | |||||||
Chi-square Pearson value | 25.1 | 1.2 | 45.2 | 334.2 | |||||||